AKR1B10 and psoriasis: Importantly, although AKR1B10 has been previously recognized as a key regulatory molecule in the onset and progression of inflammatory diseases (Guo et al., 2024; Sumantran et al., 2016), including psoriasis, our study provides substantial new evidence that establishes it as a core functional target of XYJDY.